Sylvester et al reported scores for recurrence and progression of a Ta or T1 carcinoma of the urinary bladder. The authors are from multiple institutions in Belgium and The Netherlands.
Patient select: Ta or T1 urothelial carcinoma of the urinary bladder
Parameters:
(1) number of tumors
(2) tumor size in cm (unspecified for multiple tumors)
(3) prior recurrence rate
(4) T category
(5) carcinoma in situ (CIS)
(6) histologic grade
Parameter |
Finding |
Points for Recurrence |
Points for Progression |
number of tumors |
1 |
0 |
0 |
|
2 to 7 |
3 |
3 |
|
>= 8 |
6 |
3 |
tumor size |
< 3 cm |
0 |
0 |
|
>= 3 cm |
3 |
3 |
prior recurrence |
primary |
0 |
0 |
|
<= 1 per year |
2 |
2 |
|
> 1 per year |
4 |
2 |
T category |
Ta (noninvasive papillary) |
0 |
0 |
|
T1 (into lamina propria) |
1 |
4 |
CIS |
no |
0 |
0 |
|
yes |
1 |
6 |
grade |
G1 |
0 |
0 |
|
G2 |
1 |
0 |
|
G3 |
2 |
5 |
score for recurrence =
= SUM(points for all 6 parameters)
score for progression =
= SUM(points for all 6 parameters)
Interpretation:
• minimum scores: 0
• maximum recurrence score: 17
• maximum progression score: 23
Progression Score |
5-Year Progression |
0 |
31% |
1 to 4 |
46% |
5 to 9 |
62% |
10 to 17 |
78% |
Reucrrence Score |
5-Year Recurrence |
0 |
0.8% |
2 to 6 |
6% |
7 to 13 |
17% |
14 to 23 |
45% |
Specialty: Hematology Oncology